Anup Patel
Neurology with Special Qualifications in Child Neurology · Columbus, OHNPI 1619912664
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Greenwich Biosciences, Inc. at 35.8% of the total. 2025 is the largest year on record at $4,713, 6.0 times the $789 reported in 2019.
Across 83 payments — averaging $169.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Greenwich Biosciences, Inc.$5K
- Lundbeck LLC$3K
- Biocodex, Inc.$2K
- Jazz Pharmaceuticals Inc.$1K
- UCB, Inc.$858
- Neurelis, Inc.$377
- plus $1K from 11 others
Across 16 payments — averaging $16,991 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GW Research Limited$271K
- UCB, Inc.$820
What the payments were for
- Consulting fees$4,40031%
- Speaking & faculty fees$4,36231%
- Food & beverage$5,31038%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Greenwich Biosciences, Inc. | 14 | $5,043 |
| Lundbeck LLC | 2 | $3,274 |
| Biocodex, Inc. | 11 | $1,739 |
| Jazz Pharmaceuticals Inc. | 20 | $1,483 |
| UCB, Inc. | 11 | $858 |
| Neurelis, Inc. | 5 | $377 |
| Neuropace, Inc. | 3 | $346 |
| Upsher-smith Laboratories LLC | 2 | $247 |
| Immedica Pharma US, Inc. | 1 | $172 |
| Livanova USA, Inc. | 3 | $159 |
| GE HealthCare | 3 | $128 |
| Eisai Inc. | 2 | $70 |
| Zogenix Inc. | 2 | $57 |
| SK Life Science, Inc. | 1 | $57 |
| AstraZeneca | 1 | $38 |
| Sarepta Therapeutics, Inc. | 1 | $24 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$4,476
- DIACOMIT$1,378
- VALTOCO$214
- ZTALMY$172
- RNS System$158
- QUDEXY XR Topiramate Extended Release Capsules$144
- RNS Neurostimulator Kit$133
- Fintepla$122
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$112
- VIGADRONE$102
How this compares
$14,088 in reported general payments places this provider in the 75th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Other neurology with special qualifications in child neurology in Columbus
- Anne ConnollyColumbus$154K
- Emily DelosreyesColumbus$79K
- Samiah Al-ZaidyColumbus$70K
- Ann PakalnisColumbus$56K
- Diana Bharucha-GoebelColumbus$40K
- Megan WaldropColumbus$40K
- Sylvia AwadallaColumbus$39K
- Kevin FlaniganColumbus$24K
- Kelsey PoissonColumbus$13K
- Melissa ChungColumbus$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.